Finally, it will be essential to determine if the Tfh-like CD4 T cells can directly recognize tumor antigens in HNSCC patients, since this will directly relate to the specificity of B cells that they support and the CD8 T cells that they might help. This evidence concerns the gene CD8A and head and neck squamous cell carcinoma.